Failure of mefloquine therapy in progressive multifocal leukoencephalopathy: report of two Japanese patients without human immunodeficiency virus infection.

Abstract

Although progressive multifocal leukoencephalopathy (PML) cases showing responses to mefloquine therapy have been reported, the efficacy of mefloquine for PML remains unclear. We report on the failure of mefloquine therapy in two Japanese patients with PML unrelated to human immunodeficiency virus. One of the patients was a 47-year-old male who had been treated with chemotherapy for Waldenström macroglobulinemia, and the other was an 81-year-old male with idiopathic CD4(+) lymphocytopenia. Diagnosis of PML was established based on MRI findings and increased JC virus DNA in the cerebrospinal fluid in both patients. Mefloquine was initiated about 5 months and 2 months after the onset of PML, respectively. During mefloquine therapy, clinical and radiological progression was observed, and JC virus DNA in the cerebrospinal fluid was increased in both patients. Both patients died about 4 months and 2 months after initiation of mefloquine, respectively. Further studies are necessary to clarify the differences between mefloquine responders and non-responders in PML.

DOI: 10.1016/j.jns.2012.11.004

Statistics

01002002014201520162017
Citations per Year

70 Citations

Semantic Scholar estimates that this publication has 70 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Kobayashi2013FailureOM, title={Failure of mefloquine therapy in progressive multifocal leukoencephalopathy: report of two Japanese patients without human immunodeficiency virus infection.}, author={Zen Kobayashi and Miho Akaza and Yoshiyuki Numasawa and Shoichiro Ishihara and Hiroyuki Tomimitsu and Kazuo Nakamichi and Masayuki Saijo and Tomohiro Morio and Norio Shimizu and Nobuo Sanjo and Shuzo Shintani and Hidehiro Mizusawa}, journal={Journal of the neurological sciences}, year={2013}, volume={324 1-2}, pages={190-4} }